BioPorto Diagnostics

Bioporto_diagnostics
Overview

BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector.

The Company’s developments include a test (NGAL) to diagnose and monitor acute kidney damage. BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases.

BioPorto Diagnostics A/S offers the range of antibodies under the AntibodyShop® brand. Focus areas include:

  • Bioactive peptides
  • Complement system and collectins
  • Cell biology

Home Page: http://www.bioporto.com and http://www.antibodyshop.com

Website: 

http://www.bioporto.com 
 

Country of Origin: 

 Denmark 
 

Coverage:  

 Indonesia 
 

Product Range:

  • APC-PCI ELISA Kit
  • Cell biology
  • Coagulation
  • Collectins and related products
  • Complement
  • Cytokines and hormones
  • Enzymes
  • Gc-globulin (Actin-free) ELISA Kit
  • Marker molecules
  • MBL Oligomer ELISA Kit
  • Microbiology
  • Miscellaneous
  • NGAL ELISA Kits
  • Oncology
  • Other blood proteins
  • Sera and Antigens